---
figid: PMC7582884__41392_2020_340_Fig1_HTML
figlink: pmc/articles/PMC7582884/figure/Fig1/
number: F1
caption: PI3K/Akt signal pathway, p53 signal pathway, and mTOR signal pathway in NPC.
  LMP1 latent membrane protein 1, LMP2A latent membrane protein 2A, PIP2 phosphatidylinositol
  4,5-bisphosphate, PIP3 phosphatidylinositol 3,4,5-trisphosphate, PTEN phosphatase,
  and tensin homolog, PI3K phosphoinositide 3-kinase, DNMT1 DNA methyltransferase
  1, SREBP1 sterol regulatory element-binding protein 1, VM vasculogenic mimicry,
  NaBu sodium butyrate, MK2 mitogen-activated protein kinase-activated protein kinase
  2, CCND1 cyclin D1, MYH9 myosin heavy chain 9, ITGB3 integrin β3, MDK midkine, FGF2
  fibroblast growth factor 2, COL1A1 collagen type I alpha 1, RBM3 RNA-binding motif
  protein 3, PNUTS phosphatase 1 nuclear-targeting subunit, CDKN3 cyclin-dependent
  kinase inhibitor 3, SQSTM1 Sequestosome-1, LZTS2 leucine zipper tumor suppressor
  2, UBQLN1 ubiquilin1, SMG1 suppressor of morphogenesis in genitalia 1, MDM2 murine
  double minute 2, COX-2 cycloxygenase-2, Bmi-1 B-cell-specific Moloney murine leukemia
  virus insertion site 1, EMT epithelial–mesenchymal transformation. Among them, LMP1,
  mTOR, PI3K, HIF-1α, miR-92a, Annexin A1, CDKN3, OCT4, c-Src, and COX-2 can be used
  as prognostic markers of NPC. The preclinical studies of NPC show that HIF-1α, COX-2
  has a good research value in targeted therapy. EGFR inhibitor, VEGF inhibitor, VEGFR
  inhibitor, and Akt inhibitor show positive effects and have less and tolerable adverse
  reactions in phase II clinical trials of NPC
pmcid: PMC7582884
papertitle: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal
  carcinoma.
reftext: Yuanbo Kang, et al. Signal Transduct Target Ther. 2020;5:245.
pmc_ranked_result_index: '105229'
pathway_score: 0.9719765
filename: 41392_2020_340_Fig1_HTML.jpg
figtitle: PI3K/Akt signal pathway, p53 signal pathway, and mTOR signal pathway in
  NPC
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7582884__41392_2020_340_Fig1_HTML.html
  '@type': Dataset
  description: PI3K/Akt signal pathway, p53 signal pathway, and mTOR signal pathway
    in NPC. LMP1 latent membrane protein 1, LMP2A latent membrane protein 2A, PIP2
    phosphatidylinositol 4,5-bisphosphate, PIP3 phosphatidylinositol 3,4,5-trisphosphate,
    PTEN phosphatase, and tensin homolog, PI3K phosphoinositide 3-kinase, DNMT1 DNA
    methyltransferase 1, SREBP1 sterol regulatory element-binding protein 1, VM vasculogenic
    mimicry, NaBu sodium butyrate, MK2 mitogen-activated protein kinase-activated
    protein kinase 2, CCND1 cyclin D1, MYH9 myosin heavy chain 9, ITGB3 integrin β3,
    MDK midkine, FGF2 fibroblast growth factor 2, COL1A1 collagen type I alpha 1,
    RBM3 RNA-binding motif protein 3, PNUTS phosphatase 1 nuclear-targeting subunit,
    CDKN3 cyclin-dependent kinase inhibitor 3, SQSTM1 Sequestosome-1, LZTS2 leucine
    zipper tumor suppressor 2, UBQLN1 ubiquilin1, SMG1 suppressor of morphogenesis
    in genitalia 1, MDM2 murine double minute 2, COX-2 cycloxygenase-2, Bmi-1 B-cell-specific
    Moloney murine leukemia virus insertion site 1, EMT epithelial–mesenchymal transformation.
    Among them, LMP1, mTOR, PI3K, HIF-1α, miR-92a, Annexin A1, CDKN3, OCT4, c-Src,
    and COX-2 can be used as prognostic markers of NPC. The preclinical studies of
    NPC show that HIF-1α, COX-2 has a good research value in targeted therapy. EGFR
    inhibitor, VEGF inhibitor, VEGFR inhibitor, and Akt inhibitor show positive effects
    and have less and tolerable adverse reactions in phase II clinical trials of NPC
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - TP53
  - MDM2
  - CDKN3
  - DNMT1
  - LZTS2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PTEN
  - PPP1R10
  - UBQLN1
  - FOXO1
  - MYH9
  - FGF2
  - GDE1
  - MYC
  - AKT2
  - AKT3
  - AKT1
  - MDK
  - SNAI1
  - SQSTM1
  - BCL2
  - COL1A1
  - JUN
  - SRC
  - RBM3
  - CCND1
  - MTOR
  - HIF1A
  - SREBF1
  - SMG1
  - NaBu
genes:
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: CDKN3
  symbol: CDKN3
  source: hgnc_symbol
  hgnc_symbol: CDKN3
  entrez: '1033'
- word: DNMT1
  symbol: DNMT1
  source: hgnc_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: LZTS2
  symbol: LZTS2
  source: hgnc_symbol
  hgnc_symbol: LZTS2
  entrez: '84445'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: р53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PNUTS
  symbol: PNUTS
  source: hgnc_alias_symbol
  hgnc_symbol: PPP1R10
  entrez: '5514'
- word: UBQLN1
  symbol: UBQLN1
  source: hgnc_symbol
  hgnc_symbol: UBQLN1
  entrez: '29979'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: MYH9
  symbol: MYH9
  source: hgnc_symbol
  hgnc_symbol: MYH9
  entrez: '4627'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: miR-16
  symbol: MIR16
  source: hgnc_alias_symbol
  hgnc_symbol: GDE1
  entrez: '51573'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MDK
  symbol: MDK
  source: hgnc_symbol
  hgnc_symbol: MDK
  entrez: '4192'
- word: Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: SQSTM1
  symbol: SQSTM1
  source: hgnc_symbol
  hgnc_symbol: SQSTM1
  entrez: '8878'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: COL1A1
  symbol: COL1A1
  source: hgnc_symbol
  hgnc_symbol: COL1A1
  entrez: '1277'
- word: C-Jun
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: c-Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: RBM3
  symbol: RBM3
  source: hgnc_symbol
  hgnc_symbol: RBM3
  entrez: '5935'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HIF-1a
  symbol: HIF1A
  source: hgnc_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: SREBP1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: SMG1
  symbol: SMG1
  source: hgnc_symbol
  hgnc_symbol: SMG1
  entrez: '23049'
chemicals:
- word: NaBu
  source: MESH
  identifier: D012964
diseases: []
figid_alias: PMC7582884__F1
redirect_from: /figures/PMC7582884__F1
figtype: Figure
---
